Prevaccine Human Papillomavirus Status in Invasive and Intraepithelial Lesions of the Vulva in New Zealand Women
Conclusions
Overall, the HPV vaccine is likely to substantially alter the profile of SCCV in our region. The results provide a baseline assessment of the HPV status of vulvar neoplasia before the introduction of the HPV vaccine.
Source: Journal of Lower Genital Tract Disease - Category: OBGYN Tags: HPV Associated Vulvovaginal Disease Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Cervical Cancer Vaccine | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | New Zealand Health | OBGYN | Squamous Cell Carcinoma | Study | Vaccines | Women